T2 BIOSYSTEMS INC's ticker is TTOO and the CUSIP is 89853L104. A total of 60 filers reported holding T2 BIOSYSTEMS INC in Q3 2020. The put-call ratio across all filers is 3.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | 0.0% | 27,990 | +897.5% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 2,806 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -57.1% | 2,806 | -39.0% | 0.00% | – |
| Q1 2021 | $7,000 | -22.2% | 4,600 | -37.5% | 0.00% | – |
| Q2 2020 | $9,000 | +80.0% | 7,363 | -15.8% | 0.00% | – |
| Q1 2020 | $5,000 | -79.2% | 8,742 | -57.8% | 0.00% | – |
| Q4 2019 | $24,000 | -22.6% | 20,739 | +64.7% | 0.00% | – |
| Q3 2019 | $31,000 | -13.9% | 12,590 | -42.7% | 0.00% | – |
| Q2 2019 | $36,000 | -14.3% | 21,971 | +35.6% | 0.00% | – |
| Q1 2019 | $42,000 | +82.6% | 16,202 | +104.8% | 0.00% | – |
| Q4 2018 | $23,000 | -68.9% | 7,911 | -20.9% | 0.00% | – |
| Q3 2018 | $74,000 | -81.7% | 10,006 | -80.9% | 0.00% | -100.0% |
| Q2 2018 | $405,000 | +2600.0% | 52,336 | +1356.6% | 0.00% | +100.0% |
| Q3 2017 | $15,000 | +150.0% | 3,593 | +81.1% | 0.00% | – |
| Q2 2017 | $6,000 | +20.0% | 1,984 | +74.5% | 0.00% | – |
| Q4 2016 | $5,000 | – | 1,137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,841,924 | $13,722,000 | 6.87% |
| Senvest Management, LLC | 2,769,931 | $20,636,000 | 1.56% |
| Bell Rock Capital LLC | 291,835 | $2,176,000 | 1.07% |
| ARDSLEY ADVISORY PARTNERS LP | 935,000 | $6,966,000 | 0.94% |
| TIGER MANAGEMENT L.L.C. | 967,585 | $7,209,000 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 677,433 | $5,047,000 | 0.59% |
| THOMPSON DAVIS & CO., INC. | 33,153 | $247,000 | 0.54% |
| PERKINS CAPITAL MANAGEMENT INC | 69,700 | $519,000 | 0.31% |
| Schonfeld Strategic Advisors LLC | 322,700 | $2,404,000 | 0.11% |
| Phoenix Investment Adviser LLC | 8,000 | $60,000 | 0.08% |